Noninfectious diseases, also called noncommunicable diseases, are conditions that cannot be transmitted from person to person and tend to develop slowly over years or decades. They are the leading cause of death worldwide by a wide margin. In 2021, these diseases accounted for roughly 43.8 million deaths globally, and age-standardized death rates had actually fallen by about 28% since 1990, even as the total number of cases climbed to 7.3 trillion across all subtypes.1PubMed Central. Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021 The gap between falling death rates and rising case counts tells a story that the rest of this article unpacks: people are living longer with these diseases, but more people are developing them, driven by an expanding web of genetic, behavioral, environmental, and social forces.
What Counts as a Noninfectious Disease
The category is broad. It includes any chronic or acute condition whose origin is not a pathogen like a virus, bacterium, or parasite. The major killers in this group are cardiovascular diseases (heart attacks, strokes, heart failure), cancers, chronic respiratory diseases (like COPD and asthma), and metabolic disorders (especially type 2 diabetes). But the umbrella also covers autoimmune diseases such as rheumatoid arthritis and lupus, neurodegenerative conditions like Alzheimer’s and Parkinson’s, chronic kidney disease, osteoporosis, and mental health disorders with strong biological underpinnings. Some of these share surprisingly similar root mechanisms beneath their very different symptoms.
Cardiovascular Disease
Heart disease and stroke remain the single largest cause of noninfectious-disease death worldwide. The underlying process behind most heart attacks and many strokes is atherosclerosis, a slow buildup of fatty deposits (plaques) inside artery walls. It begins when cholesterol-carrying particles called low-density lipoproteins get trapped beneath the inner lining of an artery, triggering a chronic inflammatory reaction.2PubMed. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans Immune cells, especially a type called macrophages, flood the area to clean up the trapped cholesterol but can themselves become overwhelmed and die, forming a growing, unstable core inside the plaque.3PubMed Central. A Lipid-Structured Model of Atherosclerosis with Macrophage Proliferation
Over time, the inflammatory cycle worsens. Oxidized lipoproteins provoke more immune-cell recruitment, more tissue damage, and eventual narrowing of the artery. If a plaque ruptures, a blood clot can form suddenly, blocking flow entirely and causing a heart attack or stroke.4PubMed Central. Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis Development High blood pressure, high cholesterol, smoking, diabetes, and physical inactivity all accelerate this process, but the underlying mechanism is fundamentally an immune-driven response to trapped fat in artery walls.
Cancer
Cancer develops when cells acquire mutations that allow them to grow without the normal controls. These mutations can come from environmental exposures (tobacco smoke, ultraviolet radiation, certain chemicals) or from random copying errors every time a cell divides. But a growing body of research points to a two-step problem. Mutations are necessary, yet they appear to be insufficient on their own. Researchers have found abundant cancer-driving mutations in tissue that looks completely normal under a microscope, which suggests that something else has to push those dormant mutated cells into active tumor growth.5PubMed Central. The critical roles of somatic mutations and environmental tumor-promoting agents in cancer risk
That “something else” appears to be non-mutagenic tumor-promoting agents, substances or conditions that do not directly damage DNA but instead create an environment where mutated cells can thrive. Chronic inflammation, hormonal imbalances, and certain dietary factors can all act as promoters. This reframes cancer risk: it is not only about avoiding mutagens (though that matters) but also about controlling the conditions that wake up dormant mutations. Obesity, for example, creates a state of chronic, low-grade inflammation that may serve as a tumor promoter independent of any direct DNA damage.
Metabolic Disorders and Diabetes
Type 2 diabetes is the poster child of metabolic noninfectious disease, and its hallmark is insulin resistance, a state in which the body’s cells stop responding properly to insulin. The primary problem appears to be a defect in how muscles take up sugar from the bloodstream. Research using imaging of living tissue suggests that fatty acid buildup inside muscle and liver cells interferes with insulin’s signaling chain, essentially jamming the lock that insulin is supposed to open.6PubMed. Mechanisms of insulin resistance in humans and possible links with inflammation
Where does that excess fat come from? Multiple sources: too many calories overall, inherited or acquired problems with how fat tissue stores energy, and defects in the cellular machinery that burns fatty acids for fuel.7PubMed Central. Insulin Resistance: From Mechanisms to Therapeutic Strategies Inflammation worsens the picture, creating a feedback loop in which inflamed fat tissue releases signals that further blunt insulin action. The causes also extend beyond metabolism in a narrow sense: gut microbiome composition, genetic variation, and even epigenetic changes set during early life can all modulate a person’s risk of developing insulin resistance.8Nature Signal Transduction and Targeted Therapy. Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Chronic Respiratory Disease
Chronic obstructive pulmonary disease (COPD) and asthma are the dominant chronic respiratory conditions. Tobacco smoking and air pollution are the primary causes of COPD, but an interesting puzzle sits at the center of the disease: only a minority of smokers actually develop it. Research has begun to identify protective mechanisms that explain why some lungs withstand decades of smoke exposure while others cannot. One line of investigation found that cells resistant to cigarette smoke extract showed a strong activation of an antioxidant enzyme called heme oxygenase-1, which neutralizes the damaging reactive chemicals that smoke generates. A protein called CEACAM6 appears to suppress this defense, potentially explaining individual vulnerability.9PubMed Central. CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD Asthma, by contrast, often starts in childhood and involves an overactive immune response in the airways, triggered by allergens, cold air, exercise, or stress. Both conditions share the feature of chronic airway inflammation, but their triggers and trajectory differ markedly.
Autoimmune and Neurodegenerative Conditions
Autoimmune diseases arise when the immune system loses the ability to distinguish the body’s own tissues from foreign invaders. The body maintains self-tolerance through a series of checkpoints, and a breakdown at any of these stages can unleash an immune attack on healthy organs.10PubMed. Breakdown of self-tolerance and the pathogenesis of autoimmunity Regulatory immune cells normally hold this process in check; when their function is impaired, diseases like type 1 diabetes, multiple sclerosis, and lupus can develop.11PubMed Central. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells What triggers this breakdown in any particular person remains unclear in most cases, though infections, hormonal shifts, and environmental exposures are all implicated.
Neurodegenerative diseases share a different but equally fundamental defect: the accumulation of misfolded proteins inside or around nerve cells. In Alzheimer’s disease, beta-amyloid proteins clump outside neurons while tau proteins tangle inside them. In Parkinson’s disease, a protein called alpha-synuclein aggregates within nerve cells.12PubMed. Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms Similar aggregation problems are seen in amyotrophic lateral sclerosis (ALS).13PubMed Central. Protein Misfolding and Aggregation as a Mechanistic Link Between Chronic Pain and Neurodegenerative Diseases The question of what initiates misfolding in the first place, and why it accelerates in some brains but not others, remains one of the most active areas of biomedical research.
Chronic Inflammation as a Common Thread
A striking pattern emerges across nearly all of these conditions: chronic, low-grade inflammation. It drives plaque formation in atherosclerosis, promotes tumor growth in cancer, worsens insulin resistance in diabetes, and damages neurons in neurodegeneration. As the body ages, a background level of inflammatory activity tends to creep upward even without infection, a phenomenon researchers call “inflammaging.” This sustained inflammatory state contributes to frailty, cardiovascular disease, neurodegeneration, metabolic dysfunction, and osteoarthritis through interconnected molecular pathways involving oxidative stress and cellular aging.14Innovative Medicines & Omics. Inflammaging as a systems-level integrator of disease: Biological foundations of chronic low-grade inflammation In the cardiovascular system specifically, this chronic inflammation impairs the lining of blood vessels, promotes scarring, and compromises heart and vascular integrity over time.15PubMed Central. Inflammaging and Senescence-Driven Extracellular Matrix Remodeling in Age-Associated Cardiovascular Disease
Understanding inflammation as a shared mechanism matters because it means that many noninfectious diseases are not truly independent. A person with poorly controlled diabetes has a heightened inflammatory state that also elevates cardiovascular risk. Someone with chronic respiratory disease faces similar systemic inflammation that can affect the heart. This interconnectedness helps explain why people with one noninfectious disease so often develop additional ones.
Diet and Ultra-Processed Foods
Dietary patterns are among the most modifiable risk factors for noninfectious disease, and in recent years, ultra-processed foods have drawn particular scrutiny. These are industrial formulations that go well beyond traditional food processing, characterized by high levels of unhealthy fats, sodium, refined sugars, and synthetic additives. In many Western countries, ultra-processed foods make up over half of daily calorie intake, and research suggests that each 10% increase in the share of calories coming from these products is associated with roughly a 12% rise in cardiovascular disease risk and a comparable increase in cancer incidence.16Aspects of Molecular Medicine. The impact of ultra-processed foods on cardiovascular diseases and cancer: Epidemiological and mechanistic insights
The harm appears to go beyond their individual nutrient profile. The highly degraded physical structure of ultra-processed foods affects how quickly sugar hits the bloodstream, how full you feel after eating, and the composition of your gut bacteria.17PubMed Central. Ultra-processed Foods and Cardiovascular Diseases: Potential Mechanisms of Action A 2025 science advisory from the American Heart Association acknowledged that most ultra-processed foods overlap with the dietary targets already flagged for heart-disease risk reduction, namely saturated fat, added sugars, and sodium, but the advisory also noted open questions about whether these foods carry additional harm beyond their nutrient content alone.18PubMed. Ultraprocessed Foods and Their Association With Cardiometabolic Health: Evidence, Gaps, and Opportunities: A Science Advisory From the American Heart Association
Environmental Exposures
Air pollution is often an invisible contributor to noninfectious disease, but its effects are not subtle. Fine particulate matter (the tiny particles known as PM2.5 that come from vehicle exhaust, industrial emissions, and wildfires) can penetrate deep into the lungs and trigger a systemic inflammatory response. Animal research has shown that chronic PM2.5 exposure prompts the bone marrow to release inflammatory immune cells into the bloodstream, generating oxidative stress throughout the vascular system through a pathway involving specific immune-signaling receptors.19PubMed Central. Chronic Fine Particulate Matter Exposure Induces Systemic Vascular Dysfunction via NADPH Oxidase and TLR4 Pathways The result is damage to blood vessel linings, increased blood pressure, and accelerated atherosclerosis, even in people who do not smoke and eat a reasonable diet.
Other environmental exposures matter too. Occupational chemical exposures, heavy metals, endocrine-disrupting compounds in plastics, and even chronic noise stress have all been linked to elevated rates of various noninfectious diseases. The important insight is that “lifestyle disease” is a somewhat misleading label. A factory worker breathing industrial fumes or a city dweller inhaling traffic exhaust may develop chronic disease not because of personal choices but because of where they live and work.
Genetics and Gene-Environment Interactions
Genes set the stage but rarely act alone. Most noninfectious diseases are not caused by a single gene variant the way sickle-cell disease is. Instead, hundreds or thousands of small genetic differences each contribute a tiny increase or decrease in risk, which researchers sum up as a polygenic risk score. What makes this genuinely interesting is how those genetic predispositions interact with lifestyle. A large study of over 382,000 people in the UK Biobank found that lifestyle factors like diet, physical activity, sedentary behavior, and sleep quality had stronger associations with heart-disease risk factors in people who carried high genetic risk scores than in those with low scores.20PubMed Central. New Insights into Polygenic Score-Lifestyle Interactions for Cardiometabolic Risk Factors from Genome-Wide Interaction Analyses
A similar pattern emerged in a study of nearly 50,000 Norwegians, which found gene-dependent effects of fitness, diet, and tobacco exposure on blood pressure.21PubMed Central. Polygenic Interactions With Environmental Exposures in Blood Pressure Regulation: The HUNT Study In practical terms, this means two people can eat the same diet and exercise the same amount, yet experience different metabolic consequences because of their genetic backgrounds. It also means that people at higher genetic risk often stand to benefit the most from lifestyle changes, not the least.
Social and Economic Drivers
Social conditions shape noninfectious disease risk in ways that go far beyond whether someone “chooses” to eat well or exercise. Poverty, housing instability, food insecurity, low educational attainment, and lack of healthcare access are increasingly recognized as fundamental causes of chronic disease, not just distant background factors.22PubMed Central. The Social Determinants of Chronic Disease A study in a large urban primary care population found a clear, cumulative link between unmet social needs and chronic conditions. People reporting three or more social needs (such as difficulty affording food, housing problems, or lack of transportation) were nearly four times as likely to screen positive for depression compared with those reporting none.23PubMed Central. The association between social needs and chronic conditions in a large, urban primary care population
Transportation barriers turned out to be one of the most consistently associated social needs across multiple chronic conditions in that study. Not being able to get to a doctor’s office, a pharmacy, or a grocery store compounds disease risk in ways that clinical treatments alone cannot fix. This is why public health experts increasingly argue that addressing noninfectious diseases requires action well beyond the health system, including affordable housing, food access, and public transportation.24PubMed. Social Determinants of Health, Chronic Disease Management, and the Role of the Primary Care Provider
The Gut Microbiome Connection
Your gut contains trillions of bacteria that, in a healthy state, help digest food, produce vitamins, train the immune system, and maintain the integrity of the intestinal lining. When this microbial community becomes unbalanced (through poor diet, antibiotics, chronic stress, or infections), the consequences ripple outward. A disrupted gut barrier, sometimes called “leaky gut,” allows bacterial toxins like lipopolysaccharide to enter the bloodstream, triggering widespread inflammation linked to obesity, fatty liver disease, cardiovascular disease, type 1 diabetes, and even neurodegeneration.25PubMed Central. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review
The gut microbiome also shapes immune function more broadly. Dysbiosis, as the imbalance is known, can lead to pathological damage to the intestinal lining, metabolic disorders, and eventually inflammatory diseases in multiple organ systems.26PubMed. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review This connects back to the ultra-processed food discussion: one of the ways those foods may cause harm is by altering gut microbial composition in ways that promote inflammation and metabolic dysfunction.
Mental Health and Chronic Disease
Depression and chronic physical illness form a vicious circle. Depression is associated with a state of chronic, low-grade inflammation and increased oxidative stress, the same biological hallmarks that drive cardiovascular disease and diabetes.27PubMed Central. So depression is an inflammatory disease, but where does the inflammation come from? The connection runs both ways: inflammatory activation of the immune system has been linked to both depressive symptoms and fatigue, and autoimmune conditions like multiple sclerosis are well known to carry elevated depression risk.28PubMed Central. The Role of Inflammation in Depression and Fatigue
Current evidence suggests that psychiatric and cardiometabolic disorders share bidirectional, overlapping pathways rather than a single causal mechanism. Stress-hormone dysregulation, insulin resistance, mitochondrial dysfunction, gut microbiome disruption, sleep disturbances, and the metabolic side effects of psychiatric medications all contribute.29PubMed Central. Metabolic Dysfunction in Psychiatric Disorders: A Narrative Review of Shared Pathways Between Mental Illness and Cardiometabolic Disease Treating the mental health condition without addressing its metabolic fallout, or treating the physical disease without attending to depression, leaves half the problem untouched.
Circadian Disruption and Shift Work
The body’s internal clock regulates far more than sleep. Heart rate, blood pressure, hormone release, immune function, and metabolism all follow roughly 24-hour cycles. When these rhythms are thrown off, by shift work, chronic jet lag, or simply staying up too late under artificial light, the health consequences are measurable. A controlled study showed that circadian misalignment by itself, independent of sleep loss, increased blood pressure and inflammatory markers in healthy adults.30PubMed Central. Circadian misalignment increases cardiovascular disease risk factors in humans This helps explain why shift workers face elevated risks of hypertension and cardiovascular disease even after accounting for traditional risk factors like diet and exercise. Circadian disruptions have also been connected to metabolic disorders, cancer, and neurodegenerative diseases.31PubMed Central. Circadian Rhythm: Biological Functions, Diseases, and Therapeutic Targets
Early Life Programming
Some noninfectious disease risk is set before a person is born. Nutritional conditions during pregnancy and early childhood can cause epigenetic changes, chemical modifications to DNA that alter how genes are expressed without changing the underlying genetic code. These modifications can persist into adulthood, affecting metabolism, fat storage, and inflammation for decades.32PubMed Central. Epigenetic Aging in Early Life: Role of Maternal and Early Childhood Nutrition The idea that a mother’s diet during pregnancy could influence her child’s risk of obesity and heart disease was once considered fringe. It now has substantial experimental backing, with research showing that gestational diabetes and maternal obesity can program the offspring’s metabolic set points through epigenetic mechanisms.33PubMed. Epigenetic programming, early life nutrition and the risk of metabolic disease This has unsettling implications for health equity: children born into nutritionally deprived environments may carry biological disadvantages that compound the social and economic ones.
The Evolutionary Mismatch Perspective
One way to make sense of why noninfectious diseases have become so common is to consider our evolutionary history. The human body was shaped over hundreds of thousands of years in environments radically different from the ones most people now inhabit. We evolved to crave calorie-dense foods (because they were scarce), to conserve energy when possible (because physical survival demanded bursts of effort, not sustained desk sitting), and to mount vigorous inflammatory responses (because infection was a constant threat). In modern environments where calories are abundant, physical labor is optional, and infectious threats are greatly reduced, those same traits become liabilities. The evolutionary mismatch hypothesis frames obesity, cardiovascular disease, and type 2 diabetes as consequences of traits that were once advantageous but are now poorly suited to current conditions.34PubMed Central. Applying an evolutionary mismatch framework to understand disease susceptibility
An illuminating counterpoint comes from studying animals that seem to defy disease. Statistical intuition says that bigger animals with more cells and longer lifespans should get more cancer. They don’t. Elephants, bowhead whales, and naked mole rats show remarkably low cancer rates despite their size or extreme longevity, a puzzle known as Peto’s paradox.35PubMed. Natural resistance to cancers in long-lived mammals: genomic mechanisms and experimental evidence to explain Peto’s paradox Comparative genomic analysis has identified hundreds of genes under strong selection in these long-lived species, many linked to DNA repair and tumor suppression. One mutation shared by bowhead whales and naked mole rats was confirmed in laboratory experiments to suppress cancer development.36International Journal of Innovative Technologies in Social Science. THE EVOLUTION OF CANCER RESISTANCE AS AN INSPIRATION FOR MODERN ONCOLOGY – A REVIEW Studying how evolution solved the cancer problem in other species may eventually help us solve it in our own.
Why Progress Has Been Uneven
Global trends show real improvement: from 2010 to 2019, the probability of dying from a noninfectious disease between birth and age 80 fell in roughly 80% of countries for both women and men. But in the remaining one-fifth of countries, mortality actually rose.37The Lancet. Worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4 The countries making progress tend to be wealthier, with stronger healthcare infrastructure, tobacco control policies, and pollution regulation. The countries falling behind are often those undergoing rapid economic transitions, where ultra-processed food availability rises, physical activity drops, and air quality worsens, all while healthcare systems remain underfunded. This uneven progress is a reminder that noninfectious diseases are not purely personal-choice problems. They are shaped by the systems people live within, from food supply chains and urban design to occupational safety standards and healthcare access.